2
12
3

 

>
CASE STUDY 1
Parenteral dosage form development of a highly insoluble molecule
>
CASE STUDY 2
Salt form optimization and lyophilized parenteral formulation development
>
CASE STUDY 3
Oral liquid formulation development
>
CASE STUDY 4
Accelerated stability studies to support a screening IND
>
CASE STUDY 5
Lead Optimization: Solubility and formulation screen for efficacy and PK studies

 

 

Request Information

 

Name:
Email:
Telephone:
Comments:

 

 

© 2004 Wolfe Laboratories, Inc. All rights reserved.